Curaleaf Holdings CURLF
OTC CURLF
$9.83 +0.64 (+6.96%)
At close: Aug 19, 2026 · 3:59 PM UTC

Curaleaf Holdings (CURLF) Non Operating Investment Income (2020 - 2021)

Curaleaf Holdings (CURLF) posted quarterly Non Operating Investment Income of -$2.8 million for Q4 2021, down 110.41% year-over-year from $27.0 million in Q4 2020, and down 110.41% quarter-over-quarter from $27.0 million in Q4 2020.

Curaleaf Holdings (CURLF) Non Operating Investment Income (2020 - 2021) Analysis & Trends

Curaleaf Holdings' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$2.8 million for Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Curaleaf Holdings 2.48 Bn 2.38 Bn 169.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -2.81 Mn
Dec 31, 2021 -2.81 Mn
Dec 31, 2020 26.95 Mn
Dec 31, 2020 26.95 Mn
Sep 30, 2020 10.61 Mn
Sep 30, 2020 10.61 Mn